Exponent (EXPO) Stock Forecast, Price Target & Predictions
EXPO Stock Forecast
Exponent stock forecast is as follows: an average price target of $104.00 (represents a -3.07% downside from EXPO’s last price of $107.29) and a rating consensus of 'Hold', based on 1 wall street analysts offering a 1-year stock forecast.
EXPO Price Target
The average price target for Exponent (EXPO) is $104.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $120.00 to $88.00. This represents a potential -3.07% downside from EXPO's last price of $107.29.
EXPO Analyst Ratings
According to 1 Wall Street analysts, Exponent's rating consensus is 'Hold'. The analyst rating breakdown for EXPO stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 1 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Exponent Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 26, 2024 | Tobey Sommer | Truist Financial | $120.00 | $105.54 | 13.70% | 11.85% |
| Jun 26, 2024 | Joshua Chan | UBS | $88.00 | $94.44 | -6.82% | -17.98% |
The latest Exponent stock forecast, released on Jul 26, 2024 by Tobey Sommer from Truist Financial, set a price target of $120.00, which represents a 13.70% increase from the stock price at the time of the forecast ($105.54), and a 11.85% increase from EXPO last price ($107.29).
Exponent Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 2 |
| Avg Price Target | - | $104.00 | $104.00 |
| Last Closing Price | $107.29 | $107.29 | $107.29 |
| Upside/Downside | -100.00% | -3.07% | -3.07% |
In the current month, the average price target of Exponent stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Exponent's last price of $107.29. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 26, 2024 | UBS | Neutral | Neutral | Hold |
Exponent's last stock rating was published by UBS on Jun 26, 2024. The company gave EXPO a "Neutral" rating, the same as its previous rate.
Exponent Financial Forecast
Exponent Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $236.77M | $133.34M | - | $140.31M | $127.36M | $127.18M | $130.28M | $128.48M | $113.51M | $116.41M | $119.88M | $116.48M | $110.11M | $98.66M | $92.05M | $105.95M | - | $101.55M | $106.51M | $99.03M | $92.14M | $95.30M |
| Avg Forecast | $132.39M | $138.80M | $139.81M | $136.74M | $120.93M | $125.66M | $130.83M | $125.98M | $119.11M | $126.39M | $130.40M | $127.12M | $111.45M | $114.00M | $118.53M | $115.00M | $102.15M | $104.13M | $106.05M | $102.80M | $90.75M | $92.80M | $87.33M | $100.40M | $97.11M | $97.25M | $95.79M | $93.53M | $89.07M | $86.37M |
| High Forecast | $133.38M | $139.83M | $140.85M | $137.76M | $121.84M | $126.30M | $131.80M | $126.92M | $119.33M | $126.44M | $131.38M | $128.07M | $112.28M | $114.85M | $118.53M | $116.24M | $103.25M | $105.26M | $107.19M | $103.91M | $91.73M | $93.80M | $88.27M | $101.49M | $98.16M | $98.30M | $96.82M | $94.54M | $106.89M | $103.64M |
| Low Forecast | $131.78M | $138.17M | $139.17M | $136.11M | $120.38M | $125.00M | $130.23M | $125.41M | $118.90M | $126.34M | $129.81M | $126.54M | $110.94M | $113.48M | $118.53M | $113.66M | $100.96M | $102.92M | $104.82M | $101.61M | $89.70M | $91.73M | $86.32M | $99.24M | $95.99M | $96.12M | $94.68M | $92.44M | $71.26M | $69.09M |
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 10 | 10 |
| Surprise % | - | - | - | - | - | - | - | - | 1.99% | 1.05% | - | 1.10% | 1.14% | 1.12% | 1.10% | 1.12% | 1.11% | 1.12% | 1.13% | 1.13% | 1.21% | 1.06% | 1.05% | 1.06% | - | 1.04% | 1.11% | 1.06% | 1.03% | 1.10% |
Exponent's average Quarter revenue forecast for Mar 24 based on 1 analysts is $125.98M, with a low forecast of $125.41M, and a high forecast of $126.92M. EXPO's average Quarter revenue forecast represents a -46.79% decrease compared to the company's last Quarter revenue of $236.77M (Dec 23).
Exponent EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 10 | 10 |
| EBITDA | - | - | - | - | - | - | - | - | $18.39M | $33.93M | - | $29.12M | $22.04M | $36.81M | $45.28M | $36.72M | $30.20M | $34.03M | $31.01M | $25.71M | $28.71M | $22.10M | $10.82M | $37.77M | - | $26.88M | $30.49M | $24.91M | $23.54M | $25.55M |
| Avg Forecast | $30.29M | $31.76M | $31.99M | $31.29M | $27.67M | $28.75M | $29.94M | $27.24M | $27.26M | $28.92M | $29.84M | $24.76M | $25.50M | $27.83M | $27.12M | $22.51M | $27.61M | $23.83M | $24.27M | $17.80M | $20.77M | $21.24M | $19.99M | $22.98M | $26.10M | $25.30M | $24.95M | $20.76M | $22.73M | $22.92M |
| High Forecast | $30.52M | $32.00M | $32.23M | $31.52M | $27.88M | $28.90M | $30.16M | $32.69M | $27.31M | $28.94M | $30.06M | $29.72M | $25.69M | $33.40M | $27.12M | $27.01M | $33.13M | $24.09M | $24.53M | $21.36M | $20.99M | $21.47M | $20.20M | $23.22M | $31.32M | $30.36M | $29.94M | $24.91M | $27.28M | $27.50M |
| Low Forecast | $30.16M | $31.62M | $31.85M | $31.15M | $27.55M | $28.60M | $29.80M | $21.79M | $27.21M | $28.91M | $29.71M | $19.81M | $25.39M | $22.27M | $27.12M | $18.01M | $22.09M | $23.55M | $23.99M | $14.24M | $20.53M | $20.99M | $19.75M | $22.71M | $20.88M | $20.24M | $19.96M | $16.61M | $18.18M | $18.33M |
| Surprise % | - | - | - | - | - | - | - | - | 0.67% | 1.17% | - | 1.18% | 0.86% | 1.32% | 1.67% | 1.63% | 1.09% | 1.43% | 1.28% | 1.44% | 1.38% | 1.04% | 0.54% | 1.64% | - | 1.06% | 1.22% | 1.20% | 1.04% | 1.11% |
1 analysts predict EXPO's average Quarter EBITDA for Mar 24 to be $27.24M, with a high of $32.69M and a low of $21.79M. This is 48.09% upper than Exponent's previous annual EBITDA (Dec 23) of $18.39M.
Exponent Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 10 | 10 |
| Net Income | - | - | - | - | - | - | - | - | $20.93M | $24.54M | - | $29.12M | $22.52M | $24.44M | $25.75M | $29.61M | $20.38M | $24.57M | $25.40M | $30.85M | $19.12M | $18.08M | $16.35M | $26.28M | - | $19.63M | $20.99M | $22.71M | $16.04M | $17.45M |
| Avg Forecast | $23.40M | $27.81M | $28.71M | $28.22M | $21.25M | $24.77M | $26.07M | $18.38M | $22.61M | $24.93M | $26.20M | $16.71M | $20.45M | $20.33M | $22.88M | $15.19M | $18.63M | $20.06M | $21.61M | $12.01M | $14.53M | $15.69M | $12.66M | $21.71M | $17.38M | $18.48M | $17.18M | $18.93M | $15.48M | $15.69M |
| High Forecast | $23.63M | $28.08M | $28.99M | $28.49M | $21.45M | $25.01M | $26.32M | $22.06M | $22.83M | $25.17M | $26.45M | $20.05M | $20.65M | $24.39M | $22.88M | $18.23M | $22.36M | $20.35M | $21.91M | $14.41M | $14.74M | $15.91M | $12.83M | $22.01M | $20.86M | $22.17M | $20.61M | $22.71M | $18.58M | $18.83M |
| Low Forecast | $23.27M | $27.65M | $28.54M | $28.05M | $21.12M | $24.62M | $25.91M | $14.71M | $22.10M | $24.42M | $26.04M | $13.37M | $20.33M | $16.26M | $22.88M | $12.15M | $14.91M | $19.76M | $21.28M | $9.61M | $14.31M | $15.45M | $12.46M | $21.38M | $13.91M | $14.78M | $13.74M | $15.14M | $12.39M | $12.55M |
| Surprise % | - | - | - | - | - | - | - | - | 0.93% | 0.98% | - | 1.74% | 1.10% | 1.20% | 1.13% | 1.95% | 1.09% | 1.22% | 1.18% | 2.57% | 1.32% | 1.15% | 1.29% | 1.21% | - | 1.06% | 1.22% | 1.20% | 1.04% | 1.11% |
Exponent's average Quarter net income forecast for Mar 24 is $18.38M, with a range of $14.71M to $22.06M. EXPO's average Quarter net income forecast represents a -12.17% decrease compared to the company's last Quarter net income of $20.93M (Dec 23).
Exponent SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 10 | 10 |
| SG&A | - | - | - | - | - | - | - | - | $5.94M | $80.03M | - | $90.02M | $81.21M | $69.51M | $64.19M | $72.99M | $72.21M | $68.33M | $74.97M | $77.81M | $71.76M | $65.25M | $71.06M | $55.52M | - | $63.98M | $67.34M | $69.64M | $50.74M | $60.29M |
| Avg Forecast | $67.43M | $70.69M | $71.21M | $69.64M | $61.59M | $64.00M | $66.63M | $64.13M | $60.67M | $64.38M | $66.42M | $58.30M | $56.77M | $66.24M | $60.37M | $53.00M | $66.02M | $53.04M | $54.02M | $41.90M | $46.22M | $47.27M | $44.48M | $51.14M | $65.23M | $60.21M | $55.10M | $58.03M | $48.99M | $54.06M |
| High Forecast | $67.93M | $71.22M | $71.74M | $70.17M | $62.06M | $64.33M | $67.13M | $76.96M | $60.78M | $64.40M | $66.91M | $69.96M | $57.19M | $79.48M | $60.37M | $63.60M | $79.23M | $53.61M | $54.60M | $50.28M | $46.72M | $47.78M | $44.96M | $51.69M | $78.28M | $72.26M | $66.12M | $69.64M | $58.79M | $64.87M |
| Low Forecast | $67.12M | $70.37M | $70.89M | $69.33M | $61.32M | $63.67M | $66.33M | $51.30M | $60.56M | $64.35M | $66.12M | $46.64M | $56.51M | $52.99M | $60.37M | $42.40M | $52.82M | $52.42M | $53.39M | $33.52M | $45.69M | $46.72M | $43.97M | $50.55M | $52.19M | $48.17M | $44.08M | $46.43M | $39.19M | $43.25M |
| Surprise % | - | - | - | - | - | - | - | - | 0.10% | 1.24% | - | 1.54% | 1.43% | 1.05% | 1.06% | 1.38% | 1.09% | 1.29% | 1.39% | 1.86% | 1.55% | 1.38% | 1.60% | 1.09% | - | 1.06% | 1.22% | 1.20% | 1.04% | 1.12% |
Exponent's average Quarter SG&A projection for Mar 24 is $64.13M, based on 1 Wall Street analysts, with a range of $51.30M to $76.96M. The forecast indicates a 979.26% rise compared to EXPO last annual SG&A of $5.94M (Dec 23).
Exponent EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 10 | 10 |
| EPS | - | - | - | - | - | - | - | - | $0.41 | $0.48 | - | $0.57 | $0.44 | $0.47 | $0.50 | $0.56 | $0.39 | $0.47 | $0.48 | $0.59 | $0.36 | $0.35 | $0.31 | $0.50 | - | $0.37 | $0.40 | $0.43 | $0.30 | $0.33 |
| Avg Forecast | $0.45 | $0.54 | $0.56 | $0.55 | $0.41 | $0.48 | $0.51 | $0.47 | $0.44 | $0.48 | $0.51 | $0.55 | $0.40 | $0.41 | $0.45 | $0.52 | $0.35 | $0.39 | $0.42 | $0.42 | $0.28 | $0.30 | $0.25 | $0.42 | $0.33 | $0.34 | $0.33 | $0.36 | $0.28 | $0.26 |
| High Forecast | $0.46 | $0.55 | $0.56 | $0.55 | $0.42 | $0.49 | $0.51 | $0.47 | $0.44 | $0.49 | $0.51 | $0.56 | $0.40 | $0.42 | $0.45 | $0.52 | $0.36 | $0.40 | $0.43 | $0.43 | $0.29 | $0.31 | $0.25 | $0.43 | $0.33 | $0.34 | $0.34 | $0.36 | $0.34 | $0.31 |
| Low Forecast | $0.45 | $0.54 | $0.55 | $0.54 | $0.41 | $0.48 | $0.50 | $0.46 | $0.43 | $0.47 | $0.51 | $0.55 | $0.39 | $0.41 | $0.45 | $0.51 | $0.35 | $0.38 | $0.41 | $0.41 | $0.28 | $0.30 | $0.24 | $0.42 | $0.32 | $0.33 | $0.33 | $0.35 | $0.22 | $0.21 |
| Surprise % | - | - | - | - | - | - | - | - | 0.93% | 0.99% | - | 1.03% | 1.11% | 1.13% | 1.12% | 1.09% | 1.10% | 1.21% | 1.14% | 1.40% | 1.27% | 1.15% | 1.26% | 1.18% | - | 1.09% | 1.20% | 1.21% | 1.07% | 1.27% |
According to 1 Wall Street analysts, Exponent's projected average Quarter EPS for Mar 24 is $0.47, with a low estimate of $0.46 and a high estimate of $0.47. This represents a 13.71% increase compared to EXPO previous annual EPS of $0.41 (Dec 23).
Exponent Peer Comparison by Price Target
EXPO Forecast FAQ
Is Exponent a good buy?
No, according to 1 Wall Street analysts, Exponent (EXPO) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of EXPO's total ratings.
What is EXPO's price target?
Exponent (EXPO) average price target is $104 with a range of $88 to $120, implying a -3.07% from its last price of $107.29. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Exponent stock go up soon?
According to Wall Street analysts' prediction for EXPO stock, the company can go down by -3.07% (from the last price of $107.29 to the average price target of $104), up by 11.85% based on the highest stock price target, and down by -17.98% based on the lowest stock price target.
Can Exponent stock reach $200?
EXPO's average twelve months analyst stock price target of $104 does not support the claim that Exponent can reach $200 in the near future.
What are Exponent's analysts' financial forecasts?
Exponent's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $503.39M (high $506.86M, low $501.02M), average EBITDA is $113.61M (high $119.63M, low $107.75M), average net income is $90.47M (high $94.84M, low $86.37M), average SG&A $256.36M (high $270.47M, low $242.62M), and average EPS is $1.87 (high $1.88, low $1.85). EXPO's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $547.72M (high $551.82M, low $545.24M), average EBITDA is $125.34M (high $126.28M, low $124.77M), average net income is $108.14M (high $109.2M, low $107.51M), average SG&A $278.98M (high $281.06M, low $277.71M), and average EPS is $2.1 (high $2.12, low $2.09).
Did the EXPO's actual financial results beat the analysts' financial forecasts?
Based on Exponent's last annual report (Dec 2022), the company's revenue was $513.29M, beating the average analysts forecast of $458.98M by 11.83%. Apple's EBITDA was $140.84M, beating the average prediction of $102.97M by 36.78%. The company's net income was $102.33M, beating the average estimation of $78.85M by 29.77%. Apple's SG&A was $287.9M, beating the average forecast of $236.37M by 21.80%. Lastly, the company's EPS was $1.98, beating the average prediction of $1.77 by 11.73%. In terms of the last quarterly report (Dec 2023), Exponent's revenue was $236.77M, beating the average analysts' forecast of $119.11M by 98.78%. The company's EBITDA was $18.39M, missing the average prediction of $27.26M by -32.52%. Exponent's net income was $20.93M, missing the average estimation of $22.61M by -7.42%. The company's SG&A was $5.94M, missing the average forecast of $60.67M by -90.21%. Lastly, the company's EPS was $0.41, missing the average prediction of $0.439 by -6.57%